The management of severe hyponatraemia is a challenging task for intensivists. It should be based on underlying pathophysiology, especially the duration of hyponatraemia (acute vs. chronic) and the presence or absence of severe neurologic symptoms. We describe a case of severe community-acquired hyponatraemia in which central pontine myelinolysis developed several days after discharge from the intensive care unit, despite a gradual increase of plasma sodium levels during the intensive care unit stay.
Acute severe hyponatraemia is a life-threatening medical emergency. If left untreated it causes cerebral oedema that can lead to coma, seizures, neurologic damage, herniation and death of the patient. Hypoxic patients, premenopausal females and children are prone to develop severe hyponatraemic encephalopathy postoperatively 1 . Hyponatraemia is quite common in the intensive care unit (ICU) setting, with an incidence of up to 30%, however most cases are mild and asymptomatic 2 .
The correction of hyponatraemia carries the risk of osmotic demyelination, better known as central pontine myelinolysis (CPM), although the demyelination is not necessarily confined to the pons. Rapid change in sodium level is a well-defined risk factor for the development of CPM. As the clinical manifestation of acute CPM is typically delayed for several days 3 , intensivists may not necessarily recognise the development of CPM.
We present a case of severe community-acquired hyponatraemia, where despite a gradual increase of the plasma sodium level not exceeding current recommendations, CPM developed. We discuss different strategies to treat hyponatraemic patients during the stay in the ICU and to diagnose CPM.
CASE HISTORY
A 47-year-old Asian female was admitted from the emergency room to the ICU after initial laboratory tests had shown a profound electrolyte imbalance with plasma sodium of 96 mmol/l and plasma potassium of 2.5 mmol/l (Table 1) . At the time of admission to the ICU the patient was lethargic, not oriented to time and place and was not able to recall any details from her own medical history. The patient was malnourished and dehydrated, haemodynamically stable with a blood pressure of 100/50 mmHg and oxygen saturations of 99% on room air. The reason for presentation to the emergency room was dysphagia and altered mental status noted by the spouse who called the ambulance. Interview of the spouse revealed that the patient had been disoriented intermittently for several days with gait abnormalities and no history of trauma. According to her primary physician she had a history of mild arterial hypertension and an episode of depression in the past requiring no current treatment. There was no history of liver cirrhosis, heart failure or renal disease. The hypertension was treated with 12.5 mg hydrochlorothiazide daily, with no other regular medication.
The examination at the time of admission showed a drowsy patient, no meningism, pupils equal and reactive to light and accommodation, intact corneal and gag reflexes and no dysphagia present. Deep tendon reflexes were equal bilaterally in upper and lower limbs, with a negative Babinski reflex. Myoclonic jerks were not present. The patient withdrew all four extremities to painful stimuli, but not on request. The CT scan of the brain taken prior to admission to ICU was unremarkable. Thyroid hormones and cortisol level also were normal.
After admission to the ICU, treatment of the hyponatraemia was commenced with infusion of sodium chloride 0.9%, the patient receiving 4 l over the first 12 hours. Potassium was replaced intravenously and then orally. Within 12 hours of admission mental status improved and enteral nutrition was commenced via nasogastric tube. The change of the sodium level over the first three days is shown in Figure 1 . Thirty-two hours after admission, glucose 5% was commenced to decrease the rate of correction of serum sodium. At the time of discharge from ICU the patient was fully oriented and the neurologic examination was normal. The sodium level had risen by 25 mmol/l to an absolute value of 121 mmol/l during the 70 hours of ICU treatment. The patient remained stable over the following days and was switched to oral intake. During the four following days the sodium rose further to 131 mmol/l, facilitated by oral intake but also by intravenous sodium chloride. Thirteen days after admission to the hospital new onset drowsiness was noted. The neurological examination was otherwise normal at that time. A magnetic resonance imaging (MRI) scan ( Figure 2 ) showed evidence of pontine myelinolysis. An inflammatory reason for the radiological findings was ruled out by lumbar puncture. Daily plasmapheresis with human albumin was started, however after five days her neurological condition deteriorated further and the patient developed dysdiadochokinesis, gait abnormality, muscle rigidity both on the upper and lower limbs and mild delirium. A follow-up MRI on day 24 showed marked progression of the pontine myelinolysis with extra-pontine myelinolysis (Figure 3) .
Computed tomography scan of the thorax demonstrated a 3×1.5 cm centrally located right lung tumour, with enlarged mediastinal lymph nodes. Pathological examination of bronchoscopic biopsies taken from the lung tumour showed no malignancy, but showed lymphatic tissue with necrosis. The polymerase chain reaction demonstrated DNA of Mycobacterium tuberculosis in the material, confirming the diagnosis of lymph node tuberculosis and the patient was commenced on tuberculosis medication. However, the neurologic symptoms had improved slowly over the weeks, and three months after the initial presentation the patient's neurologic symptoms had recovered completely.
DISCUSSION
Acquired hyponatraemia of inpatients is commonly related to the administration of fluids combined with a reduced ability to excrete excessive free water. However, a wider range of causes can lead to chronically acquired hyponatraemia, including use of thiazide diuretics and nonsteroidal anti-inflammatory drugs. Cases of severe hyponatraemia have also been reported in marathon runners and patients with adrenal insufficiency and hypothyroidism. Furthermore, dilutional hyponatraemia may be caused by inadequate anti-diuretic hormone secretion or central nervous disease, neoplasms with ectopic hormone production, pulmonary disease and endocrine disease 4, 5 .
Therapeutic approaches to hyponatraemia should take the underlying pathophysiology into account. When hyponatraemia develops over a short period of time (<48 hours, e.g. postoperative course or exercise induced hyponatraemia), it is generally believed that cerebral oedema results from the inability of neuronal cells to extrude solutes at the necessary rate. In these cases, a rapid increase in plasma sodium by 2 to 4 mmol/l seems justified because of the substantial effect on intracerebral pressure 6 . In slowly developing hyponatraemia (≥48 hours), neuronal cells may adapt by extrusion of organic osmolytes from their cytoplasm. These patients may present with less severe symptoms and have a lower risk of brain herniation. However, in severely hyponatraemic patients with lethargy, delirium, seizures or respiratory failure due to neurogenic pulmonary oedema, some authors also recommend an initial more rapid rise in sodium levels (i.e. 8 to 10 mmol/l in four to six hours) to avoid acute deterioration 7 . Moreover, slow correction of symptomatic patients might increase mortality 8, 9 .
For hypovolaemic patients, fluid replacement with normal saline will lead to an increase of sodium. However, the direct effect will be limited because of volume shift out of the cell. The more important effect is the restoration of euvolaemia which subsequently suppresses the anti-diuretic hormone secretion. Nonetheless, adding potassium might be necessary because of the low potassium levels frequently associated with hypovolaemic patients.
Osmotic demyelinisation may occur if chronic hyponatraemia is corrected too fast because the rate of lost organic osmolytes re-entering into cells may be too slow in comparison to extracellular rising sodium levels. Patients with severe malnutrition, alcoholism or advanced liver disease may be especially susceptible to the osmotic demyelination syndrome. To avoid CPM, experts recommend that the total increase in sodium plasma levels during the first 48 hours should not exceed 20 mmol/l 1, 5, 10, 11 . Therapy of overly rapid correction can be difficult. The rise in any given hour is less important than the increase over 48 hours. Therefore discontinuation of hypertonic saline or oral salt substitution should be sufficient if rapid rise occurs. Additionally, urinary water loss can be matched with oral water or intravenous glucose solution in order to slow the rise or bring it to a halt.
In our case, we decided to restore euvolaemia using normal saline and added potassium and plasma sodium increased by 25 mmol/l within 70 hours. The literature has been concerned with avoiding a rapid rise of the sodium level. Our case shows that despite sodium substitution within recommended levels, CPM still can develop either due to severe hyponatraemia itself or many other comorbid conditions 1, 5 . It is also important to keep in mind that failing to treat severe hyponatraemia in an effort to avoid CPM may lead to severe brain damage or death of the patient.
The diagnosis of CPM is made based on MRI. Osmotic demyelinisation is characterised by high signal intensity lesions on T2-weighted images in the central pons in the region of demyelination. Typically there is sparing of the peripheral pons. Commonly the descending corticospinal tracts are spared. Central pontine myelinolysis is not associated with enhancement or significant mass effect. Involvement of extrapontine structures includes cerebral white matter and internal capsule and also, less commonly, basal ganglia and thalamus (as in this patient).
Therapy of CPM is difficult. Isolated case reports suggest that steroids 13 , imidazolpyridine tartrate 14 or plasmapheresis may be promising options 15, 16 .
In the case presented, we saw a slow resolution of symptoms. In general, time seems to play a pivotal role and recovery of CPM with a good neurologic outcome has been reported in many cases 15, 17 .
